SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Marksans Pharma
Marksans Pharma
BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 05, 16:01
57.95
2.8 (5.08%)
VOLUME 1,036,258
LIVE
NSE
Feb 05, 16:01
57.95
2.8 (5.08%)
VOLUME 4,070,452
Download Annual Report PDF Format 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Marksans Pharma

------------------- in Rs. Cr. -------------------
Sep '15 Jun '15 Mar '15 Dec '14 Sep '14
Net Sales/Income from operations 117.08 102.32 91.74 105.64 107.55
Other Operating Income -- 2.30 3.09 -- --
Total Income From Operations 117.08 104.62 94.83 105.64 107.55
EXPENDITURE
Consumption of Raw Materials 50.09 44.76 49.61 52.43 46.63
Purchase of Traded Goods 5.26 5.97 3.22 4.87 6.74
Increase/Decrease in Stocks 3.03 -1.77 -1.36 -5.63 5.90
Power & Fuel -- -- -- -- --
Employees Cost 5.51 5.31 7.06 5.32 5.46
Depreciation 3.67 2.66 2.41 2.22 2.16
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 12.19 11.19 15.49 13.02 10.24
P/L Before Other Inc. , Int., Excpt. Items & Tax 37.34 36.51 18.39 33.42 30.44
Other Income -- -- -- -- --
P/L Before Int., Excpt. Items & Tax 37.34 36.51 18.39 33.42 30.44
Interest 1.60 2.38 1.50 5.33 3.74
P/L Before Exceptional Items & Tax 35.74 34.13 16.89 28.09 26.69
Exceptional Items -- -- -- -- --
P/L Before Tax 35.74 34.13 16.89 28.09 26.69
Tax 7.20 10.25 4.59 11.57 6.67
P/L After Tax from Ordinary Activities 28.54 23.88 12.31 16.52 20.02
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 28.54 23.88 12.31 16.52 20.02
Equity Share Capital 40.93 40.93 40.93 38.53 38.53
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.70 0.58 0.30 0.43 0.52
Diluted EPS 0.70 0.58 0.30 0.43 0.52
EPS After Extra Ordinary
Basic EPS 0.70 0.58 0.30 0.43 0.52
Diluted EPS 0.70 0.58 0.30 0.43 0.52
Public Share Holding
No Of Shares (Crores) 21.18 21.18 21.18 18.78 18.78
Share Holding (%) 51.75 51.75 51.75 48.74 48.75
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 19.75 19.75 19.75 19.75 19.75
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 48.25 48.25 48.25 51.26 51.25
Notes
Source : Dion Global Solutions Limited
Quick Links for marksanspharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.